5-fluorodopa has been researched along with carbidopa, levodopa drug combination in 1 studies
| Studies (5-fluorodopa) | Trials (5-fluorodopa) | Recent Studies (post-2010) (5-fluorodopa) | Studies (carbidopa, levodopa drug combination) | Trials (carbidopa, levodopa drug combination) | Recent Studies (post-2010) (carbidopa, levodopa drug combination) |
|---|---|---|---|---|---|
| 32 | 1 | 5 | 736 | 153 | 345 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, AE | 1 |
1 review(s) available for 5-fluorodopa and carbidopa, levodopa drug combination
| Article | Year |
|---|---|
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed | 1995 |